ClinicalTrials.gg

Global Blood Therapeutics clinical trials

Acquired by Pfizer, Oct 5, 2022 · source ↗

The registry lists 9 studies whose lead sponsor is Global Blood Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2020.

Before and after it joined Pfizer

First submitted before Global Blood Therapeutics became part of Pfizer
9
First submitted after Global Blood Therapeutics became part of Pfizer
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Global Blood Therapeutics’ studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

All 9 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed778%
  • Stopped early222%

Phase

  • Phase 16
  • Phase 23

Where

  • United States7
  • United Kingdom3

Over the years

  1. 14
  2. 15
  3. 516
  4. 17
  5. 18
  6. 19
  7. 20
  8. 21
  9. 22
  10. 23
  11. 24
  12. 25
  13. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Global Blood Therapeutics9 studies

Something wrong with this grouping? Tell us on the Pfizer page.

Studies

Recruiting first, then most recently updated. Showing 9 of 9. All Pfizer studies →